PMID: 38468288 Transl Res Dach1 deficiency drives alveolar epithelium apoptosis in pulmonary fibrosis via modulating C-Jun/Bim activity
Which is why our decision to phase out coverage of glucagon-like peptide 1 (GLP-1) weight loss drugs such as Wegovy, Zepbound and Saxenda for large group, fully insured members has been so difficult
7.4.2 Vascular cognitive impairment Given the strong indication of reduced risk of vascular dementia, dedicated trials are necessary to evaluate semaglutide in patients with established vascular cognitive impairment or those at high risk
Originally developed to help manage type 2 diabetes by regulating blood sugar and improving insulin response, semaglutide has also shown significant benefits in weight managementa growing area of focus in aesthetic medicine
Tendon and ligament repair, gastrointestinal mucosal healing, soft tissue recovery, and neuroprotective signaling are all supported by reproducible rodent and in vitro work, while the human evidence remains limited to one unpublished Phase 2 IBD trial and a small number of preliminary studies